149 related articles for article (PubMed ID: 28861972)
1. [Discovery of potential ATP-sensitive potassium channel openers with potential hypotensive activity from Chinese herbs based on molecular simulation].
Li Y; Jiang LD; Chen X; He YS; Li GY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):264-271. PubMed ID: 28861972
[TBL] [Abstract][Full Text] [Related]
2. [Discovery of potential LXRβ agonists from Chinese herbs using molecular simulation methods].
Luo GG; Lu F; Qiao LS; Li Y; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2016 Aug; 41(16):3065-3071. PubMed ID: 28920350
[TBL] [Abstract][Full Text] [Related]
3. [Method of traditional Chinese medicine formula design based on 3D-database pharmacophore search and patent retrieval].
He YS; Sun ZY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4411-7. PubMed ID: 25850277
[TBL] [Abstract][Full Text] [Related]
4. [Study on lipid-lowering traditional Chinese medicines based on pharmacophore technology and patent retrieval].
Huo XQ; He YS; Qiao LS; Sun ZY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(24):4839-43. PubMed ID: 25898588
[TBL] [Abstract][Full Text] [Related]
5. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening.
Mo SL; Liu WF; Li CG; Zhou ZW; Luo HB; Chew H; Liang J; Zhou SF
Curr Pharm Biotechnol; 2012 Jul; 13(9):1640-704. PubMed ID: 22039821
[TBL] [Abstract][Full Text] [Related]
7. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
8. First universal pharmacophore model for hERG1 K
Durdagi S; Erol I; Salmas RE; Patterson M; Noskov SY
J Mol Graph Model; 2017 Jun; 74():153-170. PubMed ID: 28499268
[TBL] [Abstract][Full Text] [Related]
9. [Virtual screening for natural CETP inhibitors by structure-based pharmacophore].
Huo XQ; Qiao LS; Jiang LD; He YS; Li GY; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3063-7. PubMed ID: 26677712
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.
Lee YH; Yi GS
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N-pyridyl and pyrimidine benzamides as potent antiepileptic agents.
Malik R; Mehta P; Srivastava S; Choudhary BS; Sharma M
J Recept Signal Transduct Res; 2017 Jun; 37(3):259-266. PubMed ID: 27607834
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 7 agonists: chemical feature based pharmacophore identification and molecular docking studies.
Yu H; Jin H; Sun L; Zhang L; Sun G; Wang Z; Yu Y
PLoS One; 2013; 8(3):e56514. PubMed ID: 23526932
[TBL] [Abstract][Full Text] [Related]
13. Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
Kaur M; Silakari O
J Biomol Struct Dyn; 2017 Nov; 35(14):3043-3060. PubMed ID: 27678281
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
[TBL] [Abstract][Full Text] [Related]
15. A combination of pharmacophore modeling, molecular docking and virtual screening for iNOS inhibitors from Chinese herbs.
Wang X; Ren Z; He Y; Xiang Y; Zhang Y; Qiao Y
Biomed Mater Eng; 2014; 24(1):1315-22. PubMed ID: 24212027
[TBL] [Abstract][Full Text] [Related]
16. Discovery of promising FtsZ inhibitors by E-pharmacophore, 3D-QSAR, molecular docking study, and molecular dynamics simulation.
Qiu Y; Zhou L; Hu Y; Bao Y
J Recept Signal Transduct Res; 2019 Apr; 39(2):154-166. PubMed ID: 31355691
[TBL] [Abstract][Full Text] [Related]
17. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
Tripuraneni NS; Azam MA
J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
[TBL] [Abstract][Full Text] [Related]
18. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
Choubey SK; Jeyaraman J
J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
[TBL] [Abstract][Full Text] [Related]
20. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation.
Raafat A; Mowafy S; Abouseri SM; Fouad MA; Farag NA
Comput Biol Med; 2022 Jul; 146():105526. PubMed ID: 35487125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
